- Filed
- Aug 4, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2025 · Jul 28, 2025 | 54.79M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 54.59M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2025 | 54.51M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 53.5M sh |
| Shares Diluted | Q2 2025 · Jun 30, 2024 | 53.44M sh |
| Capex | Q2 2025 · Jun 30, 2025 | $29.16M |
| Capex | Q2 2025 · Jun 30, 2024 | $13.89M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2025 | $77.61M |
| Operating Cash Flow | Q2 2025 · Jun 30, 2024 | $62.57M |
| Long Term Debt | Q2 2025 · Jun 30, 2025 | $627.27M |
| Long Term Debt | Q2 2025 · Dec 31, 2024 | $625.43M |
| Short Term Debt | Q2 2025 · Jun 30, 2025 | $8K |
| Short Term Debt | Q2 2025 · Dec 31, 2024 | $29K |
| Cash And Equivalents | Q2 2025 · Jun 30, 2025 | $200.93M |
| Cash And Equivalents | Q2 2025 · Dec 31, 2024 | $183.94M |
| Cash And Equivalents | Q2 2025 · Jun 30, 2024 | $168.12M |
| Stockholders Equity | Q2 2025 · Jun 30, 2025 | −$263.81M |
| Stockholders Equity | Q2 2025 · Mar 31, 2025 | −$252.22M |
| Stockholders Equity | Q2 2025 · Dec 31, 2024 | −$253.11M |
| Stockholders Equity | Q2 2025 · Jun 30, 2024 | −$255.49M |
| Stockholders Equity | Q2 2025 · Mar 31, 2024 | −$227.4M |
| Stockholders Equity | Q2 2025 · Dec 31, 2023 | −$225.06M |
| Current Liabilities | Q2 2025 · Jun 30, 2025 | $450.08M |
| Current Liabilities | Q2 2025 · Dec 31, 2024 | $392.45M |
| Total Liabilities | Q2 2025 · Jun 30, 2025 | $1.08B |
| Total Liabilities | Q2 2025 · Dec 31, 2024 | $1.02B |
| Current Assets | Q2 2025 · Jun 30, 2025 | $322.52M |
| Current Assets | Q2 2025 · Dec 31, 2024 | $278.43M |
| Total Assets | Q2 2025 · Jun 30, 2025 | $936.52M |
| Total Assets | Q2 2025 · Dec 31, 2024 | $876.91M |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.18 |
| Eps Diluted | Q2 2025 · Jun 30, 2025 | −$0.18 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.48 |
| Eps Diluted | Q2 2025 · Jun 30, 2024 | −$0.58 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.18 |
| Eps Basic | Q2 2025 · Jun 30, 2025 | −$0.18 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.48 |
| Eps Basic | Q2 2025 · Jun 30, 2024 | −$0.58 |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $31.08M |
| Sga Expense | Q2 2025 · Jun 30, 2025 | $63.81M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $29.84M |
| Sga Expense restated | Q2 2025 · Jun 30, 2024 | $57.07M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$8.52M |
| Net Income | Q2 2025 · Jun 30, 2025 | −$7.36M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$24.67M |
| Net Income | Q2 2025 · Jun 30, 2024 | −$28.65M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $4.41M |
| Operating Income | Q2 2025 · Jun 30, 2025 | $15.02M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$8.21M |
| Operating Income | Q2 2025 · Jun 30, 2024 | −$357K |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $91.39M |
| Cost Of Revenue | Q2 2025 · Jun 30, 2025 | $184.24M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $82.95M |
| Cost Of Revenue restated | Q2 2025 · Jun 30, 2024 | $167.41M |